Press release
Olaparib API Market Projected to Grow at 15.3% CAGR to US$ 4.41 Billion by 2034
The global olaparib active pharmaceutical ingredient (API) market is poised for significant growth over the next decade, driven by the expanding application of olaparib in oncology treatments and the increasing prevalence of various cancers worldwide. According to a new industry report released by Fact.MR, revenue from the global olaparib API market is estimated at US$ 1.07 billion in 2024 and has been evaluated to increase at an excellent CAGR of 15.3% through 2034 to achieve a value of US$ 4.41 billion by the end of 2034.Olaparib, a pioneering member of the PARP inhibitor class, has garnered attention for its efficacy in precision oncology. Initially approved for the treatment of ovarian cancer, its therapeutic indications have expanded to include breast, pancreatic, and prostate cancers, following approvals from regulatory bodies such as the FDA and EMA. This broadening scope has substantially increased the demand for olaparib API, as personalized medicine becomes more prevalent in cancer treatment protocols.
For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=5279
The market's dynamics are influenced by several factors. A significant driver is the rising global incidence of cancers amenable to olaparib treatment. For instance, in 2018, approximately 627,000 women worldwide succumbed to breast cancer, underscoring the urgent need for effective therapies. Additionally, pharmaceutical companies are investing heavily in research and clinical trials to explore olaparib's potential in combination therapies and its efficacy against other cancer types, further propelling API demand.
Geographically, North America is expected to dominate the olaparib API market, holding an estimated 37% share in 2024. This leadership position is attributed to the region's robust healthcare infrastructure and the high adoption rate of advanced cancer treatments. The FDA's approval of olaparib for multiple cancer indications has significantly boosted its utilization in the United States. In Western Europe, the market is projected to reach a value of US$ 227.4 million in 2024, while the South Asia & Pacific region is anticipated to experience the highest growth rate, with a CAGR of 18.2% from 2024 to 2034.
By cancer type, the ovarian cancer segment is projected to account for 48.2% of the market in 2024, translating to a value of approximately US$ 2.22 billion by 2034. This substantial share reflects olaparib's established efficacy in treating ovarian cancer patients with BRCA mutations. The drug's ability to extend progression-free survival has made it a cornerstone in ovarian cancer therapy.
The market also features a significant presence of Contract Manufacturing Organizations (CMOs), which are expected to contribute a value of US$ 2.61 billion by 2034. CMOs play a crucial role in meeting the increasing demand for olaparib API, offering specialized manufacturing capabilities and scalability.
Despite the positive outlook, the market faces challenges. The COVID-19 pandemic, for instance, led many pharmaceutical and biopharmaceutical companies to pivot towards developing diagnostics and treatments for the virus, potentially hindering the growth of the olaparib API market during that period. However, as the global focus shifts back to oncology, the market is expected to regain momentum.
Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=5279
The competitive landscape is characterized by the presence of several key players, including ScinoPharm Taiwan, Ltd.; Transo-Pharm USA LLC; ALP Pharm Beijing Co., Ltd; MSN Laboratories Pvt Ltd; Alembic Pharmaceuticals Limited; Exelixis Inc.; Pfizer Inc.; AstraZeneca plc.; Novartis AG; Bayer AG.; Dr. Reddy's Laboratories; and Sun Pharmaceutical Industries. These companies are actively engaged in strategies such as mergers and acquisitions, partnerships, and research collaborations to strengthen their market positions and expand their product portfolios.
In conclusion, the olaparib API market is set for robust growth, driven by the expanding therapeutic applications of olaparib, increasing cancer prevalence, and ongoing research and development efforts. While challenges such as shifting industry focus during global health crises exist, the market's fundamentals remain strong, supported by a competitive and dynamic industry landscape.
Explore More Related Studies Published by Fact.MR Research:
Dental 3D Printing Market
https://www.factmr.com/report/4361/dental-3d-printing-market
Joint Reconstruction Devices Market
https://www.factmr.com/report/joint-reconstruction-devices-market
Ulcerative Colitis Therapeutics Market
https://www.factmr.com/report/ulcerative-colitis-therapeutics-market
Cystic Fibrosis Devices Market
https://www.factmr.com/report/cystic-fibrosis-devices-market
Ostomy Care Market
https://www.factmr.com/report/4062/ostomy-care-market
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
About Fact.MR:
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Olaparib API Market Projected to Grow at 15.3% CAGR to US$ 4.41 Billion by 2034 here
News-ID: 3934092 • Views: …
More Releases from FactMR

Biobanking Market to Surge USD 147.9 Billion by 2035, Reshaping Global Research …
The biobanking industry stands at the threshold of a decade-long expansion trajectory that promises to reshape biological sample storage and research infrastructure technology. The market's journey from USD 68.5 billion in 2025 to USD 147.9 billion by 2035 This expansion underscores the industry's pivotal role in modernizing biological sample storage and advancing research infrastructure for pharmaceutical and biotechnology applications.
Biobanking's critical contribution to personalized medicine, drug discovery, and disease research positions…

Biopharmaceutical Packaging Market Set to Soar USD 58.2 Billion by 2035 - Unveil …
The global Biopharmaceutical Packaging Market is entering a decade of unprecedented expansion, set to nearly double in size from USD 28.5 billion in 2025 to USD 58.2 billion by 2035, registering a robust CAGR of 7.4%. This remarkable growth reflects the rising demand for advanced pharmaceutical packaging systems that enhance sterility, improve drug safety, and streamline regulatory compliance.
The market's trajectory is not just about scaling revenue but also about reshaping…

3D Printing in Healthcare Set to Redefine Medical Manufacturing - Market Forecas …
The 3D printing in healthcare industry stands at the threshold of a decade-long expansion trajectory that promises to reshape medical manufacturing and personalized healthcare technology. The market's journey from USD 4.2 billion in 2025 to USD 18.8 billion by 2035This remarkable growth underscores the technology's pivotal role in advancing personalized medicine, surgical precision, and medical device manufacturing, making it an investment priority for forward-looking manufacturers and healthcare technology leaders.Driven by…

Surgical Navigation Glasses Market to Skyrocket USD 6,793 Million by 2035, Growi …
The global surgical navigation glasses market is expected to reach USD 6,793 Million by 2035, up from estimated value of USD 423.0 Million in 2025. During the forecast period 2025 to 2035, the industry is projected to expand at a CAGR of 32.0%.This exponential trajectory underscores the industry's pivotal role in transforming modern surgical practices, particularly in neurosurgery, orthopedics, and minimally invasive procedures.
Fueled by the rapid adoption of Augmented Reality…
More Releases for API
API Management Market Size, Trends Analysis 2032 by Key Vendors- Google, Cloud A …
USA, New Jersey: According to Verified Market Research analysis, the global API Management Market size was valued at USD 4.37 Billion in 2024 and is projected to reach USD 33.07 Billion by 2032, growing at a CAGR of 28.77% from 2026 to 2032.
What is the current outlook of the API Management Market and its expected growth potential?
The API Management Market is witnessing robust expansion due to the growing need…
Api 607 Vs API 608: A Comprehensive Comparison Guide Of Industrial Valve
Introduction: Why are API standards so important for industrial valves?
In high-risk industries such as oil and gas, chemicals and power, the safety and reliability of valves can directly affect the stability of production systems. The standards set by API (American Petroleum Institute) are the technical bible of industrial valves around the world. Among them, API 607 and API 608 are key specifications frequently cited by engineers and buyers.
This article will…
Vehicle API Market 2023 | Futuristic Technology- CarAPI, Caruso, One Auto API, A …
The Vehicle API market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Vehicle API report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Vehicle API research report also provides insights of different regions that are…
Face Recognition API Market Growth, Business Overview 2023, and Forecast to 2030 …
Facial recognition is a way of recognizing a human face through technology. A facial detection system uses biometrics to map facial features from a photograph or video. It compares information with a database of known faces to find a match. Moreover, the accuracy of facial recognition systems has improved way better in the last decade. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger,…
API Management Market Report 2018: Segmentation by Solution (API Portal, API Gat …
Global API Management market research report provides company profile for Akana, Inc. (U.S.), Apiary, Inc. (U.S.), Axway, Inc. (France), CA Technologies, Inc. (U.S.), Cloud Elements, Inc. (U.S.), Dell Boomi, Inc. (U.S.), DigitalML (U.S.), Fiorano Software, Inc. (U.S.), Google, Inc. (U.S.), Hewlett-Packard Enterprises Co. (U.S.), IBM Corporation (U.S.), Mashape Inc. (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical…
Telecom API Market: OTT Service Providers Continue Cutting into Telecom API Prof …
The highly fragmented market of telecom API holds a staggering number of service providers and aggregators that are already offering their APIs to various telecom carriers. Alcatel Lucent, Apigee Corp., and Fortumo OU were the leading providers of telecom API from a global perspective in 2014. Telecom carriers have partnered with them and other prominent players in the past to launch APIs in the market.
According to Transparency Market Research’s latest…